Diagnostics / pathology

Europe’s AMR Strategy Depends on the Lab Result Being Right

AMR Stewardship Starts Before the Antibiotic Is Prescribed

GIST Care Looks Beyond First-Generation KIT Control

GSK’s Nuvalent Deal Turns Lung Cancer Precision Into a $10.6 Billion Access Race

J&J’s Firefly Bio Deal Puts KRAS Back Into the Oncology Arms Race

Cancer Sequencing Becomes the Operating System of Precision Oncology

Personalised Cancer Vaccines Show Longer-Term Staying Power

The ASCO Drug Race Still Runs Through Genomic Testing

Alzheimer’s Blood Testing Moves the Disease Clock Earlier
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
